Atualização do abaixo-assinadoPBS approval for the most effective Atopic Dermatitis/Eczema treatment. Dupilumab.

Fourth PBS submission underway.

Scott BoswellBrisbane, Austrália
14 de jan. de 2020

Thank you for your support of this petition for the much needed Eczema treatment Dupliumab (Dupixent).

During 2019 a third submission to the PBS was rejected.  The PBS is currently reviewing a fourth submission and has opened an opportunity for people to submit their support for the approval Dupilumab directly to the PBS board.

https://www1.health.gov.au/internet/main/publishing.nsf/Content/PBAC_online_submission_form

We encourage anyone who is suffering with Eczema to share their stories to the PBS panel to raise an awareness to our government about the severity of this condition.  I have spoken to many people since this petition started.  Hospitalisation, suicidal thoughts, desperation and a tortured life are unfortunately common talking points.

One of the common patterns I have seen is a position of defeat and lack of hope for any meaningful recovery from Eczema.  I have not only experienced a full recovery (ongoing treatment required), but I have now observed the recovery stories of thousands of people around the world. 

After 45 years of life without an effective treatment, I can tell you that Dupilumab has been very successful for many people.  It is a genuine breakthrough with outstanding global results.  If you'd like to read what others who are on this treatment are saying please join the facebook group - Dupixent (Dupilumab) Discussion Group.

Thank you again for your support. Please share this petition and the link in this article to submit your support to the PBS directly.

Copiar link
WhatsApp
Facebook
Nextdoor
E-mail
X